Farmavia is committed to advancing access to affordable medicines worldwide by prioritizing investment in manufacturing facilities that meet stringent cGMP (current Good Manufacturing Practice) standards and are recognized globally. This strategic focus has propelled Farmavia to a position of leadership within the pharmaceutical industry.

Our state-of-the-art manufacturing facilities adhere meticulously to cGMP guidelines, ensuring compliance with both national regulations and international standards. As a result, numerous dosage forms and active pharmaceutical ingredients (APIs) produced at these facilities consistently receive approval from major regulatory bodies worldwide.

Through ongoing dedication to enhancing and expanding our manufacturing capabilities, Farmavia continues to solidify its position as a global leader in the pharmaceutical sector.